Latest News about FDA
Recent news which mentions FDA
Is Psychedelic Treatment Around The Corner? MDMA For PTSD Checks Positive In MAPS' 2nd Phase 3 Trial
January 05, 2023
From Benzinga
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
January 05, 2023
From Benzinga
Treating Binge Eating Disorder With Magic Mushrooms: Phase 2 Clinical Trial Gets Thumbs Up
January 05, 2023
Tickers
TRYPF
From Benzinga
FDA Issues No Action Notice For Phathom Pharma's Investigational Candidate, Shares Plunge
January 04, 2023
Tickers
PHAT
From Benzinga
From Benzinga
FDA Permits Retail Pharmacies To Distribute Abortion Pills, Expanding Access After Supreme Court Ruling
January 04, 2023
From Benzinga
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
From Benzinga
FDA Approves MediWound's NexoBrid For Burn Treatment
December 30, 2022
From Benzinga
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
December 29, 2022
Tickers
TGTX
From Benzinga
Abbott Launches the World’s Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
December 29, 2022
Tickers
ABT
China Relaxes Approval Of Imported Games, Google Workers Dread Mass Layoffs, FDA Working On Regulating Pathways For Cannabis: Today's Top Stories
December 28, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.